- $5.16bn
- $7.03bn
- $1.16bn
Sotera Health Q2 revenue rises 9.2%, beats estimates
Stockholders' Agreement Terminated On May 13, 2026 - SEC Filing
Sotera Health rises as PE backers complete exit
Sotera Health dips as sponsors to exit stakes
Sotera Health Q1 revenue up 10%, beats estimates
Brief: Sotera Health Q1 Adjusted EPS USD 0.18 Vs. IBES Estimate USD 0.17
Brief: Sotera Health Appoints Kenneth D. Krause To The Board Of Directors
U.S. STOCKS ON THE MOVE -Erasca Inc, Regenxbio, Natgas stocks
U.S. STOCKS ON THE MOVE-American Eagle Outfitters, gold miners, EPAM
Sotera Health slips as PE sponsors reap $385 mln in share sale
U.S. STOCKS ON THE MOVE -Burlington Stores, Berkshire Hathaway, Bioventus
Sotera Health falls as PE backers to cut stakes
Brief: Sotera Health Announces Secondary Offering Of Common Stock
Sotera Health Q4 revenue beats expectations on sterigenics segment's growth
Brief: Sotera Health Announces Secondary Offering Of Common Stock
Sotera Health drops as top holders to carve stakes
Sotera Health beats Q3 estimates, raises FY profit guidance
Brief: Sotera Health Q3 Adjusted EPS USD 0.26 Vs. IBES Estimate USD 0.22
Brief: Sotera Health Enters Amendment No. 6 To Credit Agreement - SEC Filing